TPP Alberta

Buprenorphine/nalaxone moving to Type 2 status - July 2019

Effective July 15, 2019, buprenorphine/naloxone products will move from Type 1 to Type 2 TPP status in Alberta. As a result, these products will no longer require use of a secure TPP prescription form. Buprenorphine/naloxone products will continue to be monitored through TPP Alberta as a Type 2 drug.

Single entity buprenorphine (e.g., Butrans patches) and all buprenorphine products for veterinary use will remain a Type 1 TPP drug which means a secure TPP form is still required. 

TPP medication list (CPSA)

View the TPP medication list
(found on the College of Physicians & Surgeons of Alberta's website)

Medications on the list may only be dispensed pursuant to the pharmacist receiving a written prescription on the form approved by the College of Physicians & Surgeons of Alberta (CPSA) for the program.

As of July 1, 2017, the only TPP prescriptions you need to send to CPSA are prescriptions for:

  • compounded medications
  • office use
  • veterinary
  • Yukon

Please continue to mail the prescriptions listed above to CPSA on a weekly basis. Information regarding all other TPP prescriptions is provided to CPSA from dispensing events that are uploaded to Netcare. For more information on this change, check out the June 21, 2017, issue of The Link.


Triplicate Prescription Program Guide

Triplicate Pads Stolen/Missing

Triplicate Prescription Program (CPSA website)